GEFITINIB ZENTIVA 250 MG TBL FLM 30X1

What is the maximum co-payment for GEFITINIB ZENTIVA?

If the insurance company contributes, the maximum co-payment is 32 974,02 Kč. The maximum pharmacy price is 47 301,06 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

A medicine whose use is, in the public interest, appropriate to concentrate in specialized facilities pursuant to Section 15(10) of the Public Health Insurance Act. The medicine is reimbursed as ZÚLP and only from a facility that has a contract with the health insurer.

Does GEFITINIB ZENTIVA have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

14 327,04 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Gefitinib je hrazen v první linii léčby pacientů s lokálně pokročilým nebo metastazujícím nemalobuněčným karcinomem plic (stádium IIIB nebo stádium IV), starších 18 let, u kterých byly relevantní molekulárně biologickou metodou prokázány aktivační mutace EGFR. Terapie je hrazena do progrese onemocnění. Pacienti nemají symptomatické CNS metastázy. Přípravek je hrazen pro pacienty v celkovém stavu (PS) 0-2 dle ECOG.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe GEFITINIB ZENTIVA?

Prescription is not conditional on a medical specialization.

What is the composition of GEFITINIB ZENTIVA?

Gefitinib (250 mg), monohydrát laktosy, neznámá látka s kódem 3755, sodná sůl kroskarmelosy, magnesium-stearát, povidon k 30, natrium-lauryl-sulfát, polyvinylalkohol, makrogol 3350, žlutý oxid železitý, červený oxid železitý, oxid titaničitý, ointmentek. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to GEFITINIB ZENTIVA?

The medicine belongs to ATC group L01EB01 – GEFITINIB. Medicines with the same active substance can be found here.

Who manufactures GEFITINIB ZENTIVA?

Zentiva, k.s., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 24. 4. 2025. Production was terminated with effect from 30. 6. 2025. The manufacturer lists medicines with the following code as a potential substitute: